Showing results (301-310 of 321) with videos related to
Sort By:
Pageof 33
Brain : a Journal of Neurology|August 21, 2016
Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesisJakob Kreye, Nina K Wenke, Mariya Chayka, et al.Journal of Molecular Medicine (Berlin, Germany)|December 4, 2008
Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAEMarloes van Zwam, Ruth Huizinga, Marie-José Melief, et al.Neurological Research and Practice|May 13, 2026
Multicentric prognostic observational study on biomarker profile in immunotherapy-naïve patients with highly active generalized myasthenia gravis (PROGNO-MG): a study protocolFelix Kohle, Franz Felix Konen, Ulrike Grittner, et al.Therapeutic Advances in Neurological Disorders|December 28, 2023
Guideline for the management of myasthenic syndromesHeinz Wiendl, Angela Abicht, Andrew Chan, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2025
C5 complement inhibition versus FcRn modulation in generalised myasthenia gravisNiklas Huntemann, Lea Gerischer, Meret Herdick, et al.Orphanet Journal of Rare Diseases|May 12, 2017
Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 casesLukas J Schnitzler, Tobias Schreckenbach, Aleksandra Nadaj-Pakleza, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 8, 2025
Assessing post-stroke cognition in pre-clinical models: Lessons and recommendations from a multi-center studyGaia Brezzo, Kristy A Zera, Dana E Straus, et al.International Journal of Molecular Sciences|May 2, 2020
Removing Critical Gaps in Chemical Test Methods by Developing New Assays for the Identification of Thyroid Hormone System-Disrupting Chemicals-The ATHENA ProjectAndreas Kortenkamp, Marta Axelstad, Asma H Baig, et al.Journal of Neurology|July 11, 2024
Preventing long-term disability in CIDP: the role of timely diagnosis and treatment monitoring in a multicenter CIDP cohortPaula Quint, Christina B Schroeter, Felix Kohle, et al.Acta Neuropathologica|June 18, 2024
Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravisChristina B Schroeter, Christopher Nelke, Frauke Stascheit, et al.Pageof 33